Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01078649
What this trial is testing

Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
CancerSolid TumorsLymphoma+1 more
Debiopharm International SA 51
Testing effectiveness (Phase 2)Ended earlyNCT03013491
What this trial is testing

PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

Who this might be right for
Solid TumorLymphoma
CytomX Therapeutics 196
Testing effectiveness (Phase 2)Ended earlyNCT04644315
What this trial is testing

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

Who this might be right for
NeoplasmsColorectal NeoplasmsMelanoma+25 more
Hoffmann-La Roche 1
Testing effectiveness (Phase 2)UnknownNCT05833984
What this trial is testing

Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Who this might be right for
Solid TumorClassic Hodgkin Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 309
Early research (Phase 1)Study completedNCT01714947
What this trial is testing

Mass Balance, Pharmacokinetics and Metabolism Study of Alisertib

Who this might be right for
Advanced Solid TumorsLymphoma
Millennium Pharmaceuticals, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT02327078
What this trial is testing

The Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

Who this might be right for
B-cell MalignanciesColorectal Cancer (CRC)Head and Neck Cancer+5 more
Incyte Corporation 307
Early research (Phase 1)Ended earlyNCT00023166
What this trial is testing

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

Who this might be right for
NeoplasmLymphomasNeoplasm Metastasis
Enzon Pharmaceuticals, Inc.
Early research (Phase 1)Active Not RecruitingNCT05460767
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid Tumors or Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 504
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Early research (Phase 1)Study completedNCT01953783
What this trial is testing

Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB

Who this might be right for
Advanced Solid TumorsLymphoma
Millennium Pharmaceuticals, Inc. 7
Early research (Phase 1)Study completedNCT02145559
What this trial is testing

A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsLung NeoplasmsCancer of Liver+2 more
University of Chicago 24
Early research (Phase 1)Ended earlyNCT02414724
What this trial is testing

Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSolid Neoplasm
Roswell Park Cancer Institute 10
Early research (Phase 1)Ended earlyNCT04609579
What this trial is testing

Study of SNX281 in Subjects With Advanced Solid Tumors and Lymphoma

Who this might be right for
Advanced Solid TumorAdvanced Lymphoma
Stingthera, Inc. 27
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Early research (Phase 1)Study completedNCT03013218
What this trial is testing

Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)

Who this might be right for
Metastatic CancerSolid TumorAdvanced Cancer+1 more
ALX Oncology Inc. 174
Early research (Phase 1)WithdrawnNCT03925428
What this trial is testing

Testing a New Anti-cancer Drug Combination, Entinostat and GSK525762C, for Advanced and Refractory Solid Tumors and Lymphomas

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmAnn Arbor Stage III B-Cell Non-Hodgkin Lymphoma+14 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT01829971
What this trial is testing

Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection

Who this might be right for
Primary Liver CancerSCLCLymphoma+4 more
Mirna Therapeutics, Inc. 155
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Ended earlyNCT01163071
What this trial is testing

Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Advanced Solid Tumors
Celgene 60
Early research (Phase 1)Study completedNCT00412997
What this trial is testing

LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma

Who this might be right for
TumorsCutaneous T-Cell Lymphoma
Novartis 14
Next Page